Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Boullin

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Journal of Neural Transmission|January 1, 1981
Platelet shape change in patients with psychiatric disorders and treated with phenothiazines, thioxanthines, butyrophenones, benzodiazepines, tricyclic antidepressants and beta-adrenergic blocking agentsD J Boullin
L'Encephale|January 1, 1979
[Biochemical methodology for studying affective disorders]D J Boullin
British Journal of Clinical Pharmacology|February 1, 1977
Effects of (+) and (-)-propranolol on the responses of the human isolated basilar artery to cerebrospinal fluid obtained from patients with subarachnoid haemorrhage and cerebral arterial spasmD J Boullin, J Mohan
British Journal of Clinical Pharmacology|January 6, 2012
Increased platelet aggregation in patients receiving chlorpromazine: responses to 5-hydroxytryptamine, dopamine and N-dimethyl dopamineD J Boullin, R P Grimes
British Journal of Pharmacology|May 1, 1971
Accumulation of quinidine by human blood platelets: effects on platelet ultrastructure and 5-hydroxytryptamineD J Boullin, R A O'Brien
British Journal of Pharmacology|May 1, 1972
Mechanisms by which human blood platelets accumulate glycine, gaba and amino acid precursors of putative neurotransmittersD J Boullin, A R Green
British Journal of Clinical Pharmacology|October 1, 1976
Effects of aspirin and prostaglandin E2 on secondary phase aggregation responses of schizophrenic patients treated with chlorpromazineD J Boullin, M W Orr
The Journal of Physiology|January 1, 1971
Abnormalities of 5-hydroxytryptamine uptake and binding by blood platelets from children with Down's syndromeD J Boullin, R A O'Brien
British Journal of Pharmacology|August 1, 1970
Accumulation of dopamine by blood platelets from normal subjects and parkinsonian patients under treatment with L-DOPAD J Boullin, R A O'Brien
British Journal of Pharmacology|April 1, 1978
Characterization of receptors mediating 5-hydroxytryptamine- and catecholamine-induced platelet aggregation, assessed by the actions of alpha- and beta-blockers, butyrophenones, 5-HT antagonists and chlorpromazineD J Boullin, P A Glenton
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Journal of Neural Transmission|January 1, 1981
Platelet shape change in patients with psychiatric disorders and treated with phenothiazines, thioxanthines, butyrophenones, benzodiazepines, tricyclic antidepressants and beta-adrenergic blocking agentsD J Boullin
L'Encephale|January 1, 1979
[Biochemical methodology for studying affective disorders]D J Boullin
British Journal of Clinical Pharmacology|February 1, 1977
Effects of (+) and (-)-propranolol on the responses of the human isolated basilar artery to cerebrospinal fluid obtained from patients with subarachnoid haemorrhage and cerebral arterial spasmD J Boullin, J Mohan
British Journal of Clinical Pharmacology|January 6, 2012
Increased platelet aggregation in patients receiving chlorpromazine: responses to 5-hydroxytryptamine, dopamine and N-dimethyl dopamineD J Boullin, R P Grimes
British Journal of Pharmacology|May 1, 1971
Accumulation of quinidine by human blood platelets: effects on platelet ultrastructure and 5-hydroxytryptamineD J Boullin, R A O'Brien
British Journal of Pharmacology|May 1, 1972
Mechanisms by which human blood platelets accumulate glycine, gaba and amino acid precursors of putative neurotransmittersD J Boullin, A R Green
British Journal of Clinical Pharmacology|October 1, 1976
Effects of aspirin and prostaglandin E2 on secondary phase aggregation responses of schizophrenic patients treated with chlorpromazineD J Boullin, M W Orr
The Journal of Physiology|January 1, 1971
Abnormalities of 5-hydroxytryptamine uptake and binding by blood platelets from children with Down's syndromeD J Boullin, R A O'Brien
British Journal of Pharmacology|August 1, 1970
Accumulation of dopamine by blood platelets from normal subjects and parkinsonian patients under treatment with L-DOPAD J Boullin, R A O'Brien
British Journal of Pharmacology|April 1, 1978
Characterization of receptors mediating 5-hydroxytryptamine- and catecholamine-induced platelet aggregation, assessed by the actions of alpha- and beta-blockers, butyrophenones, 5-HT antagonists and chlorpromazineD J Boullin, P A Glenton
Pageof 4